Skeletal muscle protein loss due to D-penicillamine results from reduced protein synthesis

International Journal of Biochemistry and Cell Biology

Volumn 33, Issue 10, 2001, Pages 1013-1026

  Preedy, Victor R ^a   Wassif, Wassif S ^b   Baldwin, Dianne ^b   Jones, Jenny ^b,c   Falkous, Gavin ^d   Marway, Jaspaul S ^b   Mantle, David ^d   Scott, David L ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Carbonyl; Proteases; Protein synthesis; Rat; Skeletal muscle

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMINO ACID DERIVATIVE; COPPER; CORTICOSTERONE; CREATININE; ELECTROLYTE; FREE RADICAL; INSULIN; IRON; LIOTHYRONINE; MAGNESIUM; MANGANESE; MUSCLE PROTEIN; PENICILLAMINE; RNA; UREA; ZINC;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; KIDNEY INJURY; LIVER INJURY; NONHUMAN; PLANTARIS MUSCLE; PROTEIN CONTENT; PROTEIN DEPLETION; PROTEIN SYNTHESIS; RAT; REDUCTION; SOLEUS MUSCLE;

ANIMALS; ANTIRHEUMATIC AGENTS; COPPER; INJECTIONS, INTRAPERITONEAL; IRON; KINETICS; LIVER; MALE; MANGANESE; MUSCLE FIBERS, FAST-TWITCH; MUSCLE FIBERS, SLOW-TWITCH; MUSCLE PROTEINS; MUSCLE, SKELETAL; ORGAN SIZE; PENICILLAMINE; RATS; RATS, WISTAR; SPECTROPHOTOMETRY, ATOMIC; TIME FACTORS; ZINC;

RATTUS NORVEGICUS;

EID: 0034896064     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(01)00062-0     Document Type: Article

References (50)

1. Management of osteoarthritis and rheumatoid arthritis: Prospects and possibilities
2. Treatment of systemic sclerosis
3. Wilson's disease: MRI with clinical correlation
4. Neuromuscular complications of D-penicillamine in rheumatoid arthritis
5. Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate
6. Acute dystonia with thalamic and brainstem lesions after initial penicillamine treatment in Wilson's disease
7. Prolonged neuromuscular blockade during a D. penicillamine-induced myasthenia
8. D-penicillamine induced myasthenia gravis: Clinical, serological and genetic findings
9. Practical recommendations and new therapies for Wilson's disease
10. Effect of dietary D-penicillamine on metabolism of copper in the rat
11. Stimulation of growth by intravenous injection of copper in weanling pigs
12. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts
13. The influence of D-penicillamine on enzymatic activities: Glucose-6-phosphate dehydrogenase. Correlation with serum levels measured in humans
14. Auto-immune complications of D-penicillamine - A possible result of zinc and magnesium depletion and of pyridoxine inactivation
15. Penicillamine nephropathy and iron
16. Teratogenic effects of D-penicillamine in rats: Relation to copper deficiency
17. The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease
18. Penicillamine-induced dermatomyositis. A case history
19. Metallothionein gene expression in mouse tissues by D-penicillamine
20. D-penicillamine induces rat hepatic metallothionein
21. The effects of lathyrogens on intestinal anastomoses in the rat
22. Cytoprotective value of lysine, penicillamine, and pyridoxal phosphate against the neurotoxicity of acetaldehyde
23. Inhibition of the metabolism of ethyl carbamate by acetaldehyde
24. The relative toxicity of disease-modifying antirheumatic drugs
25. Reversibility of D-penicillamine induced collagen alterations in rat skin and granulation tissue
26. 3H]phenylalanine
27. Plasma amino acids determined by liquid chromatography within 17 minutes
28. Effect of acute anaesthesia on synthesis of contractile and non-contractile proteins of heart muscle and mixed proteins of types I and II fibre rich skeletal muscles of rat
29. Protein synthesis in pulmonary, cardiac, and skeletal muscle in acute hypertension induced by aortic constriction in the rat
30. Oxidative damage to protein in sporadic motor neuron disease spinal cord
31. Measurement of tissue protein synthesis rates in vivo: A critical analysis of contrasting methods
32. Protein synthesis in the heart in vivo, its measurement and patho-physiological alterations
33. Amino-tRNA and tissue free amino acid pools are equilibriated after a flooding dose of phenylalanine
34. The effect of chronic ethanol ingestion on protein metabolism in type-I- and type-II-fibre-rich skeletal muscles of the rat
35. Fiber-type composition of nine rat muscles. II. Relationship to protein turnover
36. Fiber-type composition of nine rat muscles. I. Changes during the first year of life
37. Pathological recations of the skeletal muscle fibre in man
38. Frequent induction of insulin autoantibodies by D-penicillamine in patients with rheumatoid arthritis
39. Muscle glutamine concentration and protein turnover in vivo in malnutrition and in endotoxemia
40. Short-term effects of corticosterone treatment on muscle protein synthesis in relation to the response to feeding
41. A comparison of rates of protein turnover in rat diaphragm in vivo and in vitro
42. Effect of essential amino acid supplementation on muscle and plasma free amino acids in chronic uremia
43. The effect of diabetes and the redox potential on amino acid content and release by isolated rat hemidiaphragms
44. Free amino acids in muscle: Effect of muscle fiber population and denervation
45. Protein synthesis in liver and extra-hepatic tissues after partial hepatectomy
46. Oxidative damage in liver disease
47. Vitamin E inhibits protein oxidation of skeletal muscle of resting and exercised rats
48. Mechanisms for the oxygen radical-mediated toxicity of various thiol-containing compounds in cultured mammalian cells
49. Captopril inhibits proliferation of human lung fibroblasts in culture: A potential antifibrotic mechanism
50. A western blot approach to detection of human plasma protein conjugates derived from D-penicillamine